Benjamin M, Toumi H, Suzuki D, Hayashi K, McGonagle D (2009) Evidence for a distinctive pattern of bone formation in enthesophytes. Ann Rheum Dis 68:1003–1010. https://doi.org/10.1136/ard.2008.091074
Article CAS PubMed Google Scholar
Tseng HW, Pitt ME, Glant TT, McRae AF, Kenna TJ, Brown MA, Pettit AR, Thomas GP (2016) Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes. Arthritis Res Ther 18:35. https://doi.org/10.1186/s13075-015-0805-0
Article CAS PubMed PubMed Central Google Scholar
Bleil J, Sieper J, Maier R, Schlichting U, Hempfing A, Syrbe U, Appel H (2015) Cartilage in facet joints of patients with ankylosing spondylitis (AS) shows signs of cartilage degeneration rather than chondrocyte hypertrophy: implications for joint remodeling in AS. Arthritis Res Ther 17:170. https://doi.org/10.1186/s13075-015-0675-5
Article PubMed PubMed Central Google Scholar
Schett G, Lories RJ, D’Agostino MA, Elewaut D, Kirkham B, Soriano ER, McGonagle D (2017) Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol 13:731–741. https://doi.org/10.1038/nrrheum.2017.188
Article CAS PubMed Google Scholar
Ranganathan V, Gracey E, Brown MA, Inman RD, Haroon N (2017) Pathogenesis of ankylosing spondylitis - recent advances and future directions. Nat Rev Rheumatol 13:359–367. https://doi.org/10.1038/nrrheum.2017.56
Article CAS PubMed Google Scholar
Danve A, Deodhar A (2022) Treatment of axial spondyloarthritis: an update. Nat Rev Rheumatol 18:205–216. https://doi.org/10.1038/s41584-022-00761-z
Reveille JD (2015) Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. Clin Rheumatol 34:1009–1018. https://doi.org/10.1007/s10067-015-2949-3
Article PubMed PubMed Central Google Scholar
de Vries MK, van Eijk IC, van der Horst-Bruinsma IE, Peters MJ, Nurmohamed MT, Dijkmans BA, Hazenberg BP, Wolbink GJ (2009) Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis. Arthritis Rheum 61:1484–1490. https://doi.org/10.1002/art.24838
Article CAS PubMed Google Scholar
Braun J, Baraliakos X, Hermann KG, Xu S, Hsu B (2016) Serum C-reactive protein levels demonstrate predictive value for radiographic and magnetic resonance imaging outcomes in patients with active ankylosing spondylitis treated with golimumab. J Rheumatol 43:1704–1712. https://doi.org/10.3899/jrheum.160003
Article CAS PubMed Google Scholar
Inman RD (2021) Axial spondyloarthritis: current advances, future challenges. J Rheum Dis 28:55–59. https://doi.org/10.4078/jrd.2021.28.2.55
Article PubMed PubMed Central Google Scholar
Baraliakos X, Gensler LS, D’Angelo S, Iannone F, Favalli EG, de Peyrecave N, Auteri SE, Caporali R (2020) Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: a structured literature review. Ther Adv Musculoskelet Dis 12:1759720X20906040. https://doi.org/10.1177/1759720X20906040
Article PubMed PubMed Central Google Scholar
Lucientes-Continente L, Marquez-Tirado B, Goicoechea de Jorge E (2023) The factor H protein family: the switchers of the complement alternative pathway. Immunol Rev 313:25–45. https://doi.org/10.1111/imr.13166
Article CAS PubMed Google Scholar
Rus H, Cudrici C, Niculescu F (2005) The role of the complement system in innate immunity. Immunol Res 33:103–112. https://doi.org/10.1385/IR:33:2:103
Article CAS PubMed Google Scholar
West EE, Woodruff T, Fremeaux-Bacchi V, Kemper C (2023) Complement in human disease: approved and up-and-coming therapeutics. Lancet. https://doi.org/10.1016/S0140-6736(23)01524-6
Article PubMed PubMed Central Google Scholar
Brinch L, Vinje O, Teisberg P, Mellbye OJ, Aakesson I (1982) The in-vivo metabolism of C3 in ankylosing spondylitis. Ann Rheum Dis 41:86–89. https://doi.org/10.1136/ard.41.1.86
Article CAS PubMed PubMed Central Google Scholar
Kinsella TD, Espinoza L, Vasey FB (1975) Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis. J Rheumatol 2:308–313
Krauledat PB, Krapf FE, Manger B, Kalden JR (1985) Evaluation of plasma C3d and immune complex determinations in the assessment of disease activity of patients with rheumatoid arthritis, systemic lupus erythematosus, and spondylitis ancylopoetica. Rheumatol Int 5:97–101. https://doi.org/10.1007/BF00541327
Article CAS PubMed Google Scholar
Li T, Huang Z, Zheng B, Liao Z, Zhao L, Gu J (2010) Serum disease-associated proteins of ankylosing spondylitis: results of a preliminary study by comparative proteomics. Clin Exp Rheumatol 28:201–207
Vinje O, Moller P, Mellbye J (1984) Immunological variables and acute-phase reactants in patients with ankylosing spondylitis (Bechterew’s syndrome) and their relatives. Clin Rheumatol 3:501–513. https://doi.org/10.1007/BF02031273
Article CAS PubMed Google Scholar
Modinger Y, Loffler B, Huber-Lang M, Ignatius A (2018) Complement involvement in bone homeostasis and bone disorders. Semin Immunol 37:53–65. https://doi.org/10.1016/j.smim.2018.01.001
Article CAS PubMed Google Scholar
Alexander JJ, Sankaran JS, Seldeen KL, Thiyagarajan R, Jacob A, Quigg RJ, Troen BR, Judex S (2018) Absence of complement factor H alters bone architecture and dynamics. Immunobiology 223:761–771. https://doi.org/10.1016/j.imbio.2018.07.023
Article CAS PubMed Google Scholar
Liu S, Ji W, Lu J, Tang X, Guo Y, Ji M, Xu T, Gu W, Kong D, Shen Q et al (2020) Discovery of potential serum protein biomarkers in ankylosing spondylitis using tandem mass tag-based quantitative proteomics. J Proteome Res 19:864–872. https://doi.org/10.1021/acs.jproteome.9b00676
Article CAS PubMed Google Scholar
Panayi GS, Slaney J, Williams BD (1980) Circulating immune complexes in patients with ankylosing spondylitis. Ann Rheum Dis 39:445–448. https://doi.org/10.1136/ard.39.5.445
Article CAS PubMed PubMed Central Google Scholar
Rodahl E, Iversen OJ (1986) Analysis of circulating immune complexes from patients with ankylosing spondylitis by gel electrophoresis and immunoblotting using antiserum against a psoriasis associated retrovirus-like particle. Ann Rheum Dis 45:892–898. https://doi.org/10.1136/ard.45.11.892
Article CAS PubMed PubMed Central Google Scholar
Skerka C, Chen Q, Fremeaux-Bacchi V, Roumenina LT (2013) Complement factor H related proteins (CFHRs). Mol Immunol 56:170–180. https://doi.org/10.1016/j.molimm.2013.06.001
Article CAS PubMed Google Scholar
Walport MJ (2001) Complement. First of two parts. N Engl J Med 344:1058–1066. https://doi.org/10.1056/NEJM200104053441406
Article CAS PubMed Google Scholar
Lee JH, Jung JH, Kim J, Baek WK, Rhee J, Kim TH, Kim SH, Kim KP, Son CN, Kim JS (2020) Proteomic analysis of human synovial fluid reveals potential diagnostic biomarkers for ankylosing spondylitis. Clin Proteomics 17:20. https://doi.org/10.1186/s12014-020-09281-y
Article CAS PubMed PubMed Central Google Scholar
Chen Q, Manzke M, Hartmann A, Buttner M, Amann K, Pauly D, Wiesener M, Skerka C, Zipfel PF (2016) Complement factor H-related 5-hybrid proteins anchor properdin and activate complement at self-surfaces. J Am Soc Nephrol 27:1413–1425. https://doi.org/10.1681/ASN.2015020212
Article CAS PubMed Google Scholar
McRae JL, Duthy TG, Griggs KM, Ormsby RJ, Cowan PJ, Cromer BA, McKinstry WJ, Parker MW, Murphy BF, Gordon DL (2005) Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein. J Immunol 174:6250–6256. https://doi.org/10.4049/jimmunol.174.10.6250
Article CAS PubMed Google Scholar
Papp A, Papp K, Uzonyi B, Cserhalmi M, Csincsi AI, Szabo Z, Banlaki Z, Ermert D, Prohaszka Z, Erdei A et al (2022) Complement factor H-related proteins FHR1 and FHR5 interact with extracellular matrix ligands, reduce factor H regulatory activity and enhance complement activation. Front Immunol 13:845953. https://doi.org/10.3389/fimmu.2022.845953
Article CAS PubMed PubMed Central Google Scholar
van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368. https://doi.org/10.1002/art.1780270401
Yoshii T, Sotome S, Torigoe I, Maehara H, Sugata Y, Yamada T, Shinomiya K, Okawa A (2010) Isolation of osteogenic progenitor cells from trabecular bone for bone tissue engineering. Tissue Eng Part A 16:933–942. https://doi.org/10.1089/ten.TEA.2009.0105
留言 (0)